Alok Srivastava - Concepedia

Author

Alok Srivastava

Christian Medical College, Vellore ORCID

Also Known As

A Srivastava, A. SRIVASTAVA, A. Srivastava, A.K. Srivastava, ALOK SRIVASTAVA, Akansha Srivastava, Alok Srivastava, Aneil P. Srivastava, Arun Srivastava, Ashwarya Srivastava

691

Publications

18.2K

Citations

H-Index

219

Concepts

All Affiliations

Christian Medical College, Vellore Christian Medical College Inserm Hospital for Sick Children

About

Alok Srivastava is an author at Christian Medical College, Vellore specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	93	5.8K
2	Health Sciences	13	17	1.5K
3	Engineering	3	3	57
4	Management	1	1	22
5	Natural Sciences	1	1	47

Alok Srivastava

204

Publications

13.5K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the management of hemophilia Alok Srivastava, A. Brewer, Evelien P. Mauser‐Bunschoten, Haemophilia	2012	1.9K
WFH Guidelines for the Management of Hemophilia, 3rd edition Alok Srivastava, Elena Santagostino, Alison Dougall, Haemophilia	2020	1.8K
Definitions in hemophilia: communication from the SSC of the ISTH Victor S. Blanchette, Nigel S. Key, L.R. Ljung, Journal of Thrombosis and Haemostasis ImmunohematologyLaboratory HematologyGranulocytePathogenesisHematology	2014	717
Impact, Diagnosis and Treatment of von Willebrand Disease J. Evan Sadler, Erik Berntorp, Victor Boulyjenkov, Thrombosis and Haemostasis World Health OrganizationVon Willebrand DiseaseThrombosisClinical FindingVenous Thrombosis	2000	501
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study Francesco Rodeghiero, Giancarlo Castaman, Alberto Tosetto, Journal of Thrombosis and Haemostasis ThrombosisType 1Venous ThrombosisDiscriminant PowerHematology	2005	353
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity Vikram Mathews, Biju George, Kavitha M. Lakshmi, Blood	2005	338
Quality Control Guidelines for Clinical-Grade Human Induced Pluripotent Stem Cell Lines Stephen Sullivan, Glyn Stacey, Chihiro Akazawa, Regenerative Medicine Adult Stem CellIpsc LineBiomedical EngineeringEmbryologyMinimum Dataset	2018	260
Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data Vikram Mathews, Biju George, Ezhilarasi Chendamarai, Journal of Clinical Oncology Long-term Follow-up DataSingle-agent Arsenic TrioxideHematological MalignancyOncologyMixed-phenotype Acute Leukemia	2010	252
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors Dietger Niederwieser, Helen Baldomero, Nosa Bazuaye, Haematologica Transplantation MedicineImmunologyStem Cell TransplantationHematologyWorldwide Access	2021	221
Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity Flora Peyvandi, D’Elia Michele, Paula Bolton‐Maggs, Journal of Thrombosis and Haemostasis ThrombosisBlood PlateletClinical EpidemiologyHematologyCoagulant Factor Activity	2012	177

Page 1